BMY:NYE-Bristol-Myers Squibb Company

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing

USD 48.16

Change

0.00 (0.00)%

Market Cap

USD 93.95B

Volume

0.01B

Analyst Target

USD 56.70
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-24 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
SCYB Schwab Strategic Trust

+0.08 (+0.16%)

N/A

ETFs Containing BMY

MEDX Horizon Kinetics Medical .. 5.62 % 0.00 %

-0.08 (-0.25%)

USD 0.75B
LIFE-B:CA Evolve Global Healthcare .. 5.03 % 0.00 %

-0.24 (-0.25%)

CAD 0.01B
XGES:LSE Xtrackers MSCI Genomic He.. 4.63 % 0.00 %

-0.22 (-0.25%)

USD 3.51M
IHE iShares U.S. Pharmaceutic.. 4.51 % 0.42 %

-0.13 (-0.25%)

USD 0.69B
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.22 % 0.00 %

-0.34 (-0.25%)

USD 0.15B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.21 % 0.00 %

-0.20 (-0.25%)

USD 3.51M
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.51 % 0.00 %

-0.15 (-0.25%)

USD 0.01B
USMV:LSE Ossiam US Minimum Varianc.. 3.00 % 0.00 %

-0.40 (-0.25%)

USD 0.01B
MVUS:PA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

N/A

USD 0.01B
SPMV:PA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

N/A

USD 7.79M
OSX2:F Ossiam Lux - Ossiam US Mi.. 3.00 % 0.00 %

-2.00 (-0.25%)

N/A
OSX2:XETRA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

-1.15 (-0.25%)

USD 0.12B
WTD9:F WisdomTree US Equity Inco.. 2.98 % 0.00 %

-0.10 (-0.25%)

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.98 % 0.00 %

-0.07 (-0.25%)

USD 0.64M
WTEU:F WisdomTree US Equity Inco.. 2.98 % 0.00 %

-0.10 (-0.25%)

USD 0.11B
WTD9:XETRA WisdomTree Issuer ICAV - .. 2.98 % 0.00 %

-0.06 (-0.25%)

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 2.98 % 0.00 %

-0.01 (-0.25%)

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 2.98 % 0.00 %

-0.05 (-0.25%)

USD 0.11B
DHS:SW WisdomTree US Equity Inco.. 2.95 % 0.00 %

-0.05 (-0.25%)

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.95 % 0.00 %

N/A

USD 0.04B
VDIV:F VanEck Vectors ETFs N.V... 2.85 % 0.00 %

+0.11 (+-0.25%)

USD 0.64B
VDIV:XETRA VanEck Morningstar Develo.. 2.85 % 0.00 %

+0.06 (+-0.25%)

USD 0.64B
TDIV:SW VanEck Morningstar Develo.. 2.78 % 0.00 %

+0.25 (+-0.25%)

USD 0.64B
TDGB:LSE VanEck Morningstar Develo.. 2.70 % 0.00 %

+0.07 (+-0.25%)

USD 0.58B
TDIV:LSE VanEck Morningstar Develo.. 2.70 % 0.00 %

+0.16 (+-0.25%)

USD 0.64B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
DHS WisdomTree U.S. High Divi.. 2.08 % 0.38 %

+0.30 (+-0.25%)

USD 1.08B
H41D:XETRA HSBC MSCI World Value ESG.. 1.91 % 0.00 %

-0.11 (-0.25%)

USD 0.18B
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
UVDV 1.72 % 0.00 %

N/A

N/A
DEW WisdomTree Global High Di.. 1.42 % 0.58 %

+0.22 (+-0.25%)

USD 0.11B
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+1.00 (+-0.25%)

USD 0.07B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+0.01 (+-0.25%)

USD 0.30B
SPXB ProShares S&P 500® Bond .. 1.32 % 0.15 %

+0.36 (+-0.25%)

USD 9.35M
FELV Fidelity Enhanced Large C.. 0.98 % 0.00 %

-0.07 (-0.25%)

USD 1.93B
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

+2.75 (+-0.25%)

USD 0.18B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+2.85 (+-0.25%)

USD 0.16M
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+0.03 (+-0.25%)

USD 0.18B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

+0.05 (+-0.25%)

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.05 (+-0.25%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.08 (+-0.25%)

USD 0.03B
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.18B
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.24B
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.06B
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

N/A

CAD 0.48B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+0.04 (+-0.25%)

USD 0.08B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+4.00 (+-0.25%)

USD 0.06B
FTLS First Trust Long/Short Eq.. 0.00 % 1.59 %

-0.38 (-0.25%)

USD 1.04B
GBF iShares Government/Credit.. 0.00 % 0.20 %

+0.41 (+-0.25%)

USD 0.24B
JHMH 0.00 % 0.46 %

N/A

N/A
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

+0.23 (+-0.25%)

USD 1.04B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

+0.11 (+-0.25%)

USD 0.34B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.04 (-0.25%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

-0.15 (-0.25%)

USD 1.70B
RUD-U:CA RBC Quant U.S. Dividend L.. 0.00 % 0.00 %

-0.38 (-0.25%)

N/A
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RUD:CA RBC Quant US Dividend Lea.. 0.00 % 0.43 %

-0.57 (-0.25%)

CAD 0.49B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.09 (+-0.25%)

USD 1.09M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.09 (+-0.25%)

USD 1.09M
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-1.05 (-0.25%)

USD 0.03B
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-0.03 (-0.25%)

USD 0.04B
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.01 (+-0.25%)

USD 0.03B
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+1.50 (+-0.25%)

USD 0.75M
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-1.00 (-0.25%)

USD 0.04B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

-50.00 (-0.25%)

USD 0.01B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+1.75 (+-0.25%)

USD 0.08B
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

-0.39 (-0.25%)

USD 0.13B
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
KVLE KFA Value Line Dynamic Co.. 0.00 % 0.00 %

-0.04 (-0.25%)

USD 0.03B
TWIO Spinnaker ETF Series - Tr.. 0.00 % 0.00 %

+0.01 (+-0.25%)

USD 0.03B
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

+0.04 (+-0.25%)

USD 9.64M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.35% 12% F 6% D-
Dividend Return 0.79% 64% D 46% F
Total Return -6.56% 12% F 6% D-
Trailing 12 Months  
Capital Gain -22.40% 21% F 13% F
Dividend Return 2.59% 33% F 44% F
Total Return -19.80% 21% F 14% F
Trailing 5 Years  
Capital Gain -5.64% 53% F 40% F
Dividend Return 14.99% 53% F 51% F
Total Return 9.35% 53% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain 2.12% 58% F 58% F
Dividend Return 4.71% 58% F 50% F
Total Return 2.59% 53% F 51% F
Risk Return Profile  
Volatility (Standard Deviation) 18.37% 58% F 40% F
Risk Adjusted Return 25.62% 58% F 40% F
Market Capitalization 93.95B 70% C- 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.00 63% 41%
Price/Book Ratio 5.26 31% 13%
Price / Cash Flow Ratio 3.32 37% 38%
Price/Free Cash Flow Ratio 15.69 52% 36%
Management Effectiveness  
Return on Equity 37.29% 93% 93%
Return on Invested Capital 27.24% 93% 90%
Return on Assets 14.64% 96% 95%
Debt to Equity Ratio 56.50% 50% 58%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.